Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Drug News

Added 10 hours ago Drug news

FDA grants De Novo clearance for Innovo device for the treatment of stress urinary incontinence.- Atlantic Therapeutics.

Atlantic Therapeutics, a global manufacturer of innovative, garment-based pelvic floor muscle strengthening and nerve stimulation products, announced that the FDA...

Added 10 hours ago Drug news

EU approves Cabometyx for liver cancer.- Ipsen + Exelixis.

Exelixis announced that its partner Ipsen received approval from the European Commission (EC) for Cabometyx (cabozantinib) tablets as a monotherapy...

Added 10 hours ago Drug news

FDA Advisory Committees recommended approval of abuse deterrent reformulation of Roxicodone by the nasal route to manage severe pain.- SpecGx / Mallinckrodt.

SpecGx LLC , a subsidiary of Mallinckrodt plc, that operates its Specialty Generics business, announced that, in a joint meeting,...

Added 10 hours ago Drug news

Updated data from registration enabling NAVIGATOR trial of avapritinib for patients with PDGFRalpha, D842V-driven GIST and in second-, third- and fourth-line for other GIST patients. Blueprint Medicines

Blueprint Medicines Corporation announced updated data for the registration-enabling NAVIGATOR clinical trial of avapritinib, a potent and highly selective KIT...

Industry news

Added 7 days ago Industry news

BioTime Inc. and Asterias Biotherapeutics Inc. agree to merge.

BioTime, Inc. and Asterias Biotherapeutics, Inc. announced that they have entered into a definitive merger agreement whereby BioTime will acquire...

Added 29 days ago Industry news

Novartis acquires Endocyte and with it 177 Lu-PSMA 617 for the treatment of prostate cancer

Novartis announced an agreement and plan of merger with Endocyte, a US-based biopharmaceutical company focused on developing targeted therapeutics for...

Added 1 month ago Industry news

Alliqua merges with Adynxx to create a new company to promote brivoligide for the reduction of long term pain relief and the reduction of opioids.

Alliqua BioMedical, Inc. and Adynxx, Inc., a privately held biopharmaceutical company, announced that they have entered into a definitive merger...